Gilead’s Hepatitis C Combo Cuts Cure to Six Weeks, Fails at Four
Alert: HALISTER Source: BN (Bloomberg News)
Tickers GILD US (Gilead Sciences Inc) ABBV US (AbbVie Inc)
People Gregg Alton (Gilead Sciences Inc) Michael J Yee (RBC Capital Markets)
Topics Viral Hepatitis
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283